Spagnoletti, Gionata
 Distribuzione geografica
Continente #
NA - Nord America 3.700
AS - Asia 1.949
EU - Europa 1.815
SA - Sud America 375
Continente sconosciuto - Info sul continente non disponibili 109
AF - Africa 105
OC - Oceania 13
Totale 8.066
Nazione #
US - Stati Uniti d'America 3.570
SG - Singapore 971
DE - Germania 414
CN - Cina 373
IT - Italia 335
SE - Svezia 312
BR - Brasile 293
VN - Vietnam 178
FR - Francia 157
UA - Ucraina 112
GB - Regno Unito 107
IE - Irlanda 92
IN - India 80
ID - Indonesia 67
RU - Federazione Russa 61
CA - Canada 59
FI - Finlandia 57
CI - Costa d'Avorio 54
JP - Giappone 51
BD - Bangladesh 45
PL - Polonia 43
HK - Hong Kong 37
AR - Argentina 26
IQ - Iraq 26
MX - Messico 26
NL - Olanda 21
BE - Belgio 20
IR - Iran 20
TR - Turchia 19
ZA - Sudafrica 16
ES - Italia 15
AT - Austria 14
EC - Ecuador 14
CO - Colombia 13
LT - Lituania 13
AU - Australia 11
VE - Venezuela 11
KR - Corea 9
SA - Arabia Saudita 9
IL - Israele 8
JM - Giamaica 8
MA - Marocco 8
EG - Egitto 7
PH - Filippine 7
PK - Pakistan 7
SC - Seychelles 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
HN - Honduras 5
NI - Nicaragua 5
SI - Slovenia 5
BO - Bolivia 4
CL - Cile 4
CR - Costa Rica 4
DZ - Algeria 4
GT - Guatemala 4
KE - Kenya 4
KG - Kirghizistan 4
NP - Nepal 4
PT - Portogallo 4
UY - Uruguay 4
UZ - Uzbekistan 4
AM - Armenia 3
AZ - Azerbaigian 3
BB - Barbados 3
BG - Bulgaria 3
BZ - Belize 3
JO - Giordania 3
KZ - Kazakistan 3
MY - Malesia 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
EU - Europa 2
KH - Cambogia 2
LV - Lettonia 2
MD - Moldavia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
OM - Oman 2
PE - Perù 2
PR - Porto Rico 2
PY - Paraguay 2
SV - El Salvador 2
A1 - Anonimo 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GY - Guiana 1
HT - Haiti 1
Totale 7.947
Città #
Ashburn 530
Singapore 514
Chandler 488
San Jose 288
New York 111
Beijing 103
Milan 95
Dublin 90
San Mateo 77
Jacksonville 72
Council Bluffs 70
Ho Chi Minh City 70
Rome 66
Ann Arbor 65
Wilmington 62
Los Angeles 61
Jakarta 58
Abidjan 54
Lauterbourg 53
Boston 49
Hanoi 48
Tokyo 47
Frankfurt am Main 41
The Dalles 40
Fairfield 39
São Paulo 39
Redwood City 37
Santa Clara 37
Dallas 36
Princeton 34
Phoenix 33
Warsaw 33
Hong Kong 32
Munich 28
Dearborn 26
Houston 26
Moscow 26
North Bergen 26
Buffalo 25
Hefei 24
Nanjing 23
Lawrence 19
Boardman 18
Helsinki 18
Nürnberg 18
Orem 18
Brussels 17
London 17
Brooklyn 16
Toronto 16
Woodbridge 16
Atlanta 15
Chicago 15
San Francisco 15
Rio de Janeiro 13
Augusta 12
Hangzhou 12
Marseille 12
Montreal 12
Seattle 12
Shanghai 12
Turku 12
Andover 11
Paris 11
Washington 11
Amsterdam 10
Nanchang 10
Naples 10
Shenyang 10
Zhengzhou 10
Brasília 9
Chennai 9
Stockholm 9
Vilnius 9
Baghdad 8
Guangzhou 8
Haiphong 8
Hebei 8
Kent 8
Las Vegas 8
Miami 8
Nuremberg 8
Philadelphia 8
Basingstoke 7
Bremen 7
Denver 7
Hyderabad 7
Istanbul 7
Johannesburg 7
Lancaster 7
Pune 7
Redmond 7
San Diego 7
Seoul 7
Ankara 6
Boonville 6
Charlotte 6
Costa Mesa 6
Da Nang 6
Kish 6
Totale 4.295
Nome #
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 212
LAPDOCTOR: TELL ME HOW DIFFICULT WILL BE MY DONOR 205
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: results from a preliminary cross-sectional study 204
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors. 199
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 181
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 180
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 180
TO TRANSPLANT OR NOT TO TRANSPLANT: A KIDNEY WITH A GIANT CYST. CASE REPORT AND REVIEW OF THE LITERATURE 178
USE OF A SINGLE DOSE OF BASILIXIMAB AFTER MAJOR SURGICAL PROCEDURES IN KIDNEY TRANSPLANT RECIPIENTS 175
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 175
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 174
Living Kidney Donation in a Type 1 Dent's Disease Patient from His Mother 173
High-dose atorvastatin reduces oxidative stress of ischemia/reperfusion injury after isogeneic kidney transplantation in rats: in vivo, preclinical, case–control, open-label study 170
CHYLOUS ASCITES AFTER LAPAROSCOPIC LIVING DONOR NEPHRECTOMY. CASE REPORT AND REVIEW OF THE LITERATURE 166
COMBINATION OF EXTENDED-RELEASE TACROLIMUS PLUS EVEROLIMUS ONCE-DAILY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: ER-TAC VERSUS LCPT 163
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study. 161
Metabolic Syndrome and Cardiovascular Disease in Kidney Transplantation 156
Do patients who participate in a clinic experimental protocol have the same probability of success from that who were not selected or refused to participate? Outcome surveillance, safety, and bioethical considerations in kidney transplant clinical research 154
AN EASY ALGORITHM TO OPTIMIZE THE EXPOSURE TO TACROLIMUS AND EVEROLIMUS, WHEN USED IN COMBINATION 154
How Challenging Will Be My Living Donor? CT Scan and Clinical Evaluation Can Predict Technical Difficulty of Laparoscopic Donor Nephrectomy 154
Combination of Extended-Release Tacrolimus Plus Everolimus Once Daily in Dc Novo Kidney Transplant Recipients: ER-Tac vs LCPT 147
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 146
The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen. 143
Behavioural and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 143
Behavioral and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 142
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: Results from a preliminary cross-sectional study 139
Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up 138
Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report 137
Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease 132
Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy. 129
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 128
Improving outcomes of in situ split liver transplantation in Italy over the last 25 years 124
Massive Coronary Microvascular Dysfunction in Severe Anderson-Fabry Disease Cardiomyopathy 124
Evolution of causes of mortality in renal transplantation in the last 10 years 119
Evidence of evolution towards left midventricular obstruction in severe Anderson–Fabry cardiomyopathy 119
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 116
Once-a-Day Administration of Everolimus Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study 115
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors 114
Once-a-day administration of everolimus is safe in de novo renal transplant recipients: 1-year results of a pilot study 112
Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine 105
A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early (vs delayed) introduction of everolimus in De Novo Kidney transplant recipients, with a follow-up evaluation at 12 months after transplant (NEVERWOUND study) 102
Thymoglobuline plus basiliximab a mixed cocktail to start? 102
Are there any relations among transplant centre volume, surgical technique and anatomy for donor graft selection? Ten-year multicentric Italian experience on mini-invasive living donor nephrectomy 102
Incidence of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients Immunosuppressed With Sirolimus in Combination With Cyclosporine 101
Radiofrequency thermal ablation of renal graft neoplasms: Case series and literature review 100
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 97
Metabolic syndrome and cardiovascular disease in kidney transplantation 97
Higher Incidence of Acute Rejection in Renal Transplant Recipients With Low Everolimus Exposure 88
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 86
Long-Term Clinical Impact of Vesicoureteral Reflux in Kidney Transplantation 86
Systematic use of magnetic double J stent in pediatric kidney transplantation: A single-center experience 84
Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy 83
Severe silent myocardial ischemia during echocardiographic examination in a patient during cardiac screening for a kidney transplant intervention 83
Case report: Pylorus-preserving pancreatoduodenectomy for focal congenital hyperinsulinism in a 5-month-old baby 82
Prospective Clinical Trial Comparing Two Immunosuppressive Regimens, Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine, in De Novo Renal Transplant Recipients: Results at 6 Months Follow-up 82
Image-Guided Thermal Ablation in De Novo Renal Tumor Arising in Kidney Allograft: 3-Year Follow-Up. A Case Report 77
Neurologic outcome following liver transplantation for methylmalonic aciduria 76
Induction With Basiliximab Plus Thymoglobulin Is Effective and Safe in Old-for-Old Renal Transplantation: Six-Month Results of a Prospective Clinical Study 73
Risk of Kaposi Sarcoma after Solid-Organ Transplantation: Multicenter Study in 4767 Recipients in Italy, 1970-2006 63
Elderly kidney transplant recipient with intermittent fever: A case report of leishmaniasis with acute kidney injury during liposomal amphotericin B therapy 61
Retrospective analysis of a tertiary care centre of sex differences in risk factors, aetiology and short-term clinical outcome after revascularization treatment in young adults’ ischemic stroke 32
Positive Clinical, Neuropsychological, and Metabolic Impact of Liver Transplantation in Patients With Argininosuccinate Lyase Deficiency 32
Global Outcomes of Open Versus Laparoscopic Versus Robotic Donor Hepatectomy: A Prospective Study From the International LDLT Registry (LDLTregistry.org) 31
Normothermic Machine Perfusion of Explanted Human Metabolic Livers: A Proof of Concept for Studying Inborn Errors of Metabolism 28
Simultaneous or sequential kidney-liver transplantation in primary hyperoxaluria 26
Predictive Role of the INDANA CV Score System in Kidney Transplant Recipients 26
Lapdoctor: Multicentre Validation of a Scoring System for Preoperative Evaluation of Difficulty of Laparoscopic Donor Nephrectomy 25
Suture-free polyglactin 910 mesh repair of kidney graft rupture: A case report and review of literature 21
The impact of liver transplantation on health-related quality of life in (acute) intoxication-type inborn errors of metabolism 18
The Combination of Everolimus and Low Dose Cyclosporine Allows Similar Results as the Standard Tacrolimus and MMF Regimen: 3-Year Results of a Prospective Clinical Trial in Renal Transplant Recipients 16
Totale 8.066
Categoria #
all - tutte 35.620
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.620


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022420 0 0 0 0 19 20 16 88 22 36 101 118
2022/20231.186 152 172 70 212 58 150 73 96 157 5 24 17
2023/2024483 29 130 11 51 22 92 24 24 5 14 34 47
2024/20251.092 28 54 122 73 80 45 26 52 158 77 234 143
2025/20262.544 426 62 125 244 456 90 470 116 143 224 103 85
2026/20271.097 95 99 270 536 97 0 0 0 0 0 0 0
Totale 8.066